Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
t-Boc-MTSEA-Fluorescein (AC217)
Cat.#: ASSD-217
Specifications
Description t-Boc-MTSEA-Fluorescein, a thiol-specific fluorescently labeled probe, is used for ion channel and protein function and topology research. The compound can bind to cysteine residues found on proteins. Size 10 mg Applications Used for ion channel and protein topology research. Molecule Weight 628.67 Molecular formula C29H28N2O10S2 CAS Number 1042688-20-9 Solubility Soluble in DMF, DMSO and Methanol Storage Desiccate at -20° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-214 8-Aminopyrene-1,3,6-trisulfonic acid trisodium salt (AC214) 10 mg inquiry ASSD-211 5(6)-Carboxyfluorescein N-hydroxysuccinimide ester (AC211) 100 mg, 1 g inquiry ASSD-208 NBD-X, succinimidyl ester (AC208) 100 mg inquiry ASSD-197 Sulforhodamine 101 acid chloride (AC197) 10 mg, 25 mg inquiry ASSD-158 Eosin Y (AC158) 1g inquiry ASSD-200 Ethylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[3-difluoromethyl-4-phosphoanilinamidosuccinic Acid] Diamide (AC200) 500 μg inquiry ASSD-218 6-Carboxy-2′,7′-dichlorofluorescein-3′,6′-diacetatesuccinimidyl Ester (AC218) 25 mg inquiry ASSD-174 Coomassie Blue R-250 (AC174) 25 g, 100 g inquiry ASSD-173 FITC-Dextran 70 (AC173) 100 mg, 500 mg inquiry ASSD-175 5-Carboxyfluorescein-N-hydroxysuccinimide Ester (AC175) 25 mg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket